Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Shaw Warren

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Journal of Leukocyte Biology|March 2, 2011
Editorial: Control issues in sepsis: what modulates apoptosis?H Shaw Warren
Critical Care Medicine|December 13, 2005
Toll-like receptorsH Shaw Warren
Critical Care Medicine|March 28, 2009
Peroxisome proliferator-activated receptor-gamma agonists, control of bacterial outgrowth, and inflammationH Shaw Warren
Journal of Leukocyte Biology|August 1, 2009
Editorial: Mouse models to study sepsis syndrome in humansH Shaw Warren
Nature|May 7, 2004
Human genetics: an inflammatory issueKevin J Tracey, H Shaw Warren
Nature Reviews. Drug Discovery|September 6, 2014
Strategies to improve drug development for sepsisMitchell P Fink, H Shaw Warren
The Journal of Infectious Diseases|July 11, 2003
Murein lipoprotein, peptidoglycan-associated lipoprotein, and outer membrane protein A are present in purified rough and smooth lipopolysaccharidesJudith Hellman, Megan M Tehan, H Shaw Warren
The New England Journal of Medicine|December 12, 2003
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 38-2003. A 12-year-old girl with fever and comaH Shaw Warren, R Gilberto Gonzalez, Di Tian
The New England Journal of Medicine|September 27, 2002
Risks and benefits of activated protein C treatment for severe sepsisH Shaw Warren, Anthony F Suffredini, Peter Q Eichacker, et al.
Scandinavian Journal of Immunology|August 1, 1994
Responses of human T cells to dominant discrete protein antigens of Escherichia coli and Pseudomonas aeruginosaC M Kersten, R T McCluskey, H Shaw Warren, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Journal of Leukocyte Biology|March 2, 2011
Editorial: Control issues in sepsis: what modulates apoptosis?H Shaw Warren
Critical Care Medicine|December 13, 2005
Toll-like receptorsH Shaw Warren
Critical Care Medicine|March 28, 2009
Peroxisome proliferator-activated receptor-gamma agonists, control of bacterial outgrowth, and inflammationH Shaw Warren
Journal of Leukocyte Biology|August 1, 2009
Editorial: Mouse models to study sepsis syndrome in humansH Shaw Warren
Nature|May 7, 2004
Human genetics: an inflammatory issueKevin J Tracey, H Shaw Warren
Nature Reviews. Drug Discovery|September 6, 2014
Strategies to improve drug development for sepsisMitchell P Fink, H Shaw Warren
The Journal of Infectious Diseases|July 11, 2003
Murein lipoprotein, peptidoglycan-associated lipoprotein, and outer membrane protein A are present in purified rough and smooth lipopolysaccharidesJudith Hellman, Megan M Tehan, H Shaw Warren
The New England Journal of Medicine|December 12, 2003
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 38-2003. A 12-year-old girl with fever and comaH Shaw Warren, R Gilberto Gonzalez, Di Tian
The New England Journal of Medicine|September 27, 2002
Risks and benefits of activated protein C treatment for severe sepsisH Shaw Warren, Anthony F Suffredini, Peter Q Eichacker, et al.
Scandinavian Journal of Immunology|August 1, 1994
Responses of human T cells to dominant discrete protein antigens of Escherichia coli and Pseudomonas aeruginosaC M Kersten, R T McCluskey, H Shaw Warren, et al.
Pageof 7